Invitae Generation is our rigorous, evolving approach to clinical genetic testing. Since 2020, we’ve seen a 40% reduction in rates of variants of uncertain significance (VUS) with Invitae Generation technology. Learn more about how to get the answers you need for your patients when you need them: https://invit.ae/3KMoJEG
Invitae’s Post
More Relevant Posts
-
Cardiologist, #HeartSuccess Program Builder Therapy & Technology Investigator Associate Professor of Cardiovascular Medicine Associate Editor, Journal of Cardiac Failure | Dad
Patient in clinic: How it started: 35F, NICM, genetic testing neg Original BMI 40+ LVEDD 6.5 cm, LVEF 20%, LBBB How it’s going: 1. ARNi, BB, MRA, SGLT2i 2. CRT for LBBB after partial recovery on GDMT 3. GLP1 She’s down 130 lbs LV has normalized in size/fxn “Just Do It.”
To view or add a comment, sign in
-
-
📈 Enhance Your Revenue Opportunities 📈 ExtendingME Launching Soon. Partner with Extending ME and offer your patients first-of-its-kind lifetime genetic testing. Not only will you help them live healthier lives, but you’ll also enhance your revenue opportunities. Reach out to learn more! [email protected] #RevenueGrowth #GeneticTesting #HealthcareBusiness
To view or add a comment, sign in
-
-
Unveiling the complexities of genetic testing: A significant 80% of variants in ClinVar are classified as VUS or conflicted. Discover how MAVEvidence by Constantiam Biosciences is pioneering the interpretation of these ambiguous genetic findings, enhancing diagnostic accuracy and advancing patient-centric care. #GeneticTesting #MAVEvidence #HealthTech #PatientCare #vus
To view or add a comment, sign in
-
Medical necessity in genetic testing is crucial for effective treatment, optimal resource utilization, and accurate diagnoses. Read our article for detailed insight and its important on this topic. #MedicalNecessity #GeneticTesting #HealthcareOptimization #PatientCare #InsuranceCoverage #Acrev https://www.rfr.bz/llju2fc
To view or add a comment, sign in
-
Professor of Clinical Neurology at University College London, Honorary Consultant Neurologist Director of UCL Huntington’s Disease Centre, Joint Head of Department of Neurodegenerative Disease
Just out from my lab on Biorxiv: Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington’s disease. https://lnkd.in/enTVrVm5
To view or add a comment, sign in
-
Medical necessity in genetic testing is crucial for effective treatment, optimal resource utilization, and accurate diagnoses. Read our article for detailed insight and its important on this topic. #MedicalNecessity #GeneticTesting #HealthcareOptimization #PatientCare #InsuranceCoverage #Acrev https://www.rfr.bz/llju2fc
The Medical Necessity for Genetic Testing in Modern Healthcare | Acrev Solutions
To view or add a comment, sign in
-
🔬 Exploring Hemoglobinopathy and Thalassemia Testing Are you curious about the evolving landscape of hemoglobinopathy? 🩸 Dr. Robert Akkers delves into this topic, shedding light on the shifting distribution of hemoglobinopathies and the critical need for expanded thalassemia genetic testing. 🧬 In a recent blog, Dr. Akkers shares how his lab streamlined thalassemia testing, leveraging real case data. The star of the show? Devyser’s dedicated software, Amplicon Suite, which enhances data analysis. 🌟
Are you be interested in learning about the shifting distribution of hemoglobinopathy, and the need for expanded thalassemia genetic testing? Read this insightful blog that recaps how Dr. Robert Akkers and his lab implemented more streamlined thalassemia testing and used real case data to showcase how Devyser’s dedicated software, Amplicon Suite, aids data analysis. Read here: https://bit.ly/3S8vQvf Click the link to discover more about the features in Amplicon Suite ▶️ https://bit.ly/3LoFoyr #NGSTesting #LabInnovation #thalassemia #ngs #genetictesting
To view or add a comment, sign in
-
-
Are you be interested in learning about the shifting distribution of hemoglobinopathy, and the need for expanded thalassemia genetic testing? Read this insightful blog that recaps how Dr. Robert Akkers and his lab implemented more streamlined thalassemia testing and used real case data to showcase how Devyser’s dedicated software, Amplicon Suite, aids data analysis. Read here: https://bit.ly/3S8vQvf Click the link to discover more about the features in Amplicon Suite ▶️ https://bit.ly/3LoFoyr #NGSTesting #LabInnovation #thalassemia #ngs #genetictesting
To view or add a comment, sign in
-
-
In this "Hot Topic," take a closer look at familial variant targeted testing. Megan Hoenig, genetic counselor at Mayo Clinic Laboratories, guides us through a real-life case example, showcasing how this targeted testing strategy can impact clinical care for familial variants. https://bit.ly/3TlN20m
Familial Variant Targeted Testing (FMTT) - Insights
To view or add a comment, sign in
-
How to stay efficient and maintain quality in Cystic Fibrosis genetic testing? 🔬 Dr Andrew Purvis from NHS Scotland explains the impact and success of setting up Devyser CFTR 68 in his laboratory. Read for the full story → https://hubs.ly/Q02q4lK60 #CysticFibrosis #DevyserCFTR68 #NHS
To view or add a comment, sign in